Evidence map›Paper›PMID 32714082›Full record

ArticleInternational journal of medical sciences2020

Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures.

Dongli Li, Yuran Ma, Wenfeng Liu, Xiang Ren, Min Chen, Xuetao Xu, Zhaojun Sheng, Kun Zhang, Renping Zhou, Susan Goodin and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Celecoxib in oncology: targeting the COX-2/PGEFrontiers in pharmacology · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Dongli LiSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen city, 529020, China.
Yuran MaSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen city, 529020, China.
Wenfeng LiuSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen city, 529020, China.
Xiang RenSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen city, 529020, China.
Min ChenSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen city, 529020, China.
Xuetao XuSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen city, 529020, China.
Zhaojun ShengSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen city, 529020, China.
Kun ZhangSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen city, 529020, China.
Renping ZhouDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Susan GoodinRutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA.
Xi ZhengSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen city, 529020, China.
Rutgers, The State University of New Jersey · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsApoptosisCaspase 3CelecoxibCell Line, TumorCell ProliferationCell SurvivalFarnesolGene Expression Regulation, NeoplasticHumansNF-kappa BPancreatic NeoplasmsProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2SalicylatesSignal TransductionBCL2 protein, humanCASP3 protein, humanCaspase 3CelecoxibFarnesolfarnesylthiosalicylic acidNF-kappa BProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2Salicylates3D culturescelecoxibNF-κB.Pancreatic cancersalirasib

Identifiers

PMID32714082
PMCPMC7378654
OpenAlexW3044276011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.